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a  b  s  t  r  a  c  t
Developmental  exposure  to manganese  (Mn)  or  stress  can each  be detrimental  to brain
development.  Here,  Sprague-Dawley  rats  were  exposed  to two  housing  conditions  and  Mn
from postnatal  day (P)4–28.  Within  each  litter  two  males  and  two females  were  assigned
to  the following  groups:  0 (vehicle),  50,  or  100  mg/kg  Mn  by  gavage  every  other  day.  Half
the litters  were  reared  in  cages  with  standard  bedding  and  half  with  no  bedding.  One
pair/group  in  each  litter  had  an  acute  shallow  water  stressor  before  tissue  collection  (i.e.,
standing  in  shallow  water).  Separate  litters  were assessed  at P11,  19, or  29. Mn-treated  rats
raised in  standard  cages  showed  no  change  in  baseline  corticosterone  but  following  acute
stress increased  more  than controls  on  P19;  no  Mn  effects  were  seen  on P11  or P29.  Mn
increased  neostriatal  dopamine  in females  at P19 and  norepinephrine  at  P11  and  P29.  Mn
increased  hippocampal  dopamine  at P11  and  P29  and  5-HT  at P29  regardless  of housing  or
sex. Mn  had  no  effect  on  hypothalamic  dopamine,  but  increased  norepinephrine  in males
at P29  and  5-HT  in  males  at all ages  irrespective  of rearing  condition.  Barren  reared  rats
showed  no  or  opposite  effects  of Mn,  i.e.,  barren  rearing  + Mn  attenuated  corticosterone
increases  to acute stress.  Barren  rearing  also altered  the Mn-induced  changes  in  dopamine
and  norepinephrine  in  the neostriatum,  but  not  in  the hippocampus.  Barren  rearing  caused
a Mn-associated  increase  in hypothalamic  dopamine  at P19  and  P29  not  seen  in standard
reared  Mn-treated  groups
function of  age,  stress  (ac
© 2014  The  Authors.  Publ
the CC  BY-NC-N
Abbreviations: 5-HT, 5-hydroxytryptamine (serotonin); DA, dopamine; NE, no
homovanillic  acid; 5-HIAA, 5-hydroxyindolacetic acid; SWS, shallow water stress
∗ Corresponding authors. Tel.: +513 636 8624 MTW;  513 636 8622 CVV; fax: +
E-mail addresses: charles.vorhees@cchmc.org (C.V. Vorhees), devon.graham@
(R.M. Amos-Kroohs), amanda.braun@cchmc.org (A.A. Braun), curtis.grace@covan
(T.L.  Schaefer), matthew.skelton@cchmc.org (M.R. Skelton), kmerikso@uncg.edu 
(M.  Aschner), Michael.williams@cchmc.org (M.T. Williams).
1 Department of Pharmacology, Vanderbilt University School of Medicine, 23rd
2 Covance Laboratories, Inc., Discovery and Translational Service, 671 South M
3 Div. of Psychiatry, Cincinnati Children’s Research Foundation, Cincinnati, OH
http://dx.doi.org/10.1016/j.toxrep.2014.10.004
2214-7500/© 2014 The Authors. Published by Elsevier Ireland Ltd. Th
(http://creativecommons.org/licenses/by-nc-nd/3.0/)..  Developmental  Mn  alters  monoamines  and  corticosterone  as  a
ute  and  chronic),  and sex.
ished  by Elsevier  Ireland  Ltd.  This  is  an  open  access  article  under
D  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
repinephrine; Mn,  manganese; DOPAC, dihydroxyphenylacetic acid; HVA,
.
513 636 3912.
vanderbilt.edu (D.L. Graham), robyn.amos-kroohs@cchmc.org
ce.com (C.E. Grace), tori.schaefer@cchmc.org
(K.M. Erikson), michael.aschner@einstein.yu.edu
Ave. South; 476 RRB, Nashville, TN 37232-6600 (DLG).
eridian Rd., Greenﬁeld, IN 46140 (CEG).
 45229.
is is an open access article under the CC BY-NC-ND license
logy Rep
1
h
c
p
g
o
s
r
c
s
[
o
p
t
s
l
e
o
e
5
h
a
c
o
i
u
M
p
w
g
i
w
d
l
w
d
s
m
l
m
s
e
(
a
s
a
s
r
n
c
c
i
p
s
p
t
pC.V. Vorhees et al. / Toxico
. Introduction
Manganese (Mn) is an essential nutrient for maintaining
omeostasis [1]. However, Mn  over exposure (MnOE), most
ommonly  seen in adults from occupational exposure, can
roduce  symptoms similar to Parkinson’s disease (man-
anism), especially motor deﬁcits [1–3]. Cognitive and
ther  behavioral deﬁcits also occur [4,5]. This phenotype is
een  in rodent models of MnOE as well. For instance, MnOE
esults  in spatial working memory deﬁcits and increases in
ompulsive  behaviors in non-human primates [6] and in
patial  memory deﬁcits in rodents in the Morris water maze
7].  MnOE also has effects when it occurs during devel-
pment [8] that include deﬁcits in executive function and
assive  avoidance [9]. Neonatal rats accumulate Mn  more
han  similarly exposed adults because of lower excretion
hortly after birth (postnatal day (P) 8–10) compared with
ater  time points (P18–P19); however, even P18–P19 rats
xcrete  Mn  at lower rates than adults [10–12]; this devel-
pmental pattern is mediated in part by reduced biliary
xcretion of Mn  during the pre-weaning period [13–15].
4MnCl2 tracer analysis in rats found that Mn  uptake was
ighest in brain (with regional speciﬁcity), followed by liver
nd  blood. Developmentally, the highest uptake is at P5
ompared with other ages from 5 weeks to almost 2 years
f  age [16]. Physiologically-based pharmacokinetic model-
ng  in rats veriﬁes the above ﬁndings and the higher Mn
ptake  in the neonatal period is likely because of higher
n  requirements during rapid growth as seen during the
re-weaning period [17]. This leaves open the question of
hether  the same developmental mechanisms that permit
reater  Mn uptake for nutritional requirements may  act to
ncrease  exposure when Mn  levels are increased beyond
hat is nutritionally needed. Ingestion of excess Mn in chil-
ren  occurs for a number of reasons, including, but not
imited to infant baby formulas or polluted air, soil, or well
ater.  MnOE children show cognitive deﬁcits, behavioral
isinhibition, decreased IQ, and decreased performance on
chool-related tasks [18–22].
Soy-based baby formula ([23,9]) can contain 5, 10, or
ore  times the levels of Mn  found in cow-based formu-
as  and 100 times or more than found in human breast
ilk [1,24,25]. Unfortunately, one of the factors that makes
oy-based formulas attractive is that they are often less
xpensive. Thus, children in lower socioeconomic status
SES)  families are more likely to be fed soy-based formulas,
nd  this is in addition to having a greater risk for expo-
ure to stress because of the impoverished environments
ssociated with lower SES. The combination of MnOE and
tress  during development may  interact to create greater
isk  than either factor alone.
Chronic  stress is a known risk factor to the developing
ervous system. Children in low SES families have higher
ortisol levels suggesting a heightened level of stress as
ompared with children of higher SES strata [26–28]. Dur-
ng  late gestation and early infancy humans go through a
eriod  of stress-induced adrenal quiescence. In rodents a
imilar  period occurs, known as the stress hyporesponsive
eriod (SHRP) that takes place from P4 to P14 in rats. During
he  SHRP, the adrenal response of the hypothalamic-
ituitary-adrenal (HPA) axis is down-regulated resulting inorts 1 (2014) 1046–1061 1047
lower  circulating glucocorticoids to stressors. This period
is  hypothesized to be protective to defend the developing
brain from excitotoxicity produced by stress-induced ele-
vations  in corticosteroids [29,30]. Hence, the SHRP, while
buffering the effects of stress has a ﬁnite capacity; chronic
stress during this period may  exceed this buffering capacity
and  result in adverse effects [31–35].
The purpose of this study was  to test the hypothesis that
chronic stress alters the effects of MnOE during neonatal
development in rodents. Accordingly, we  combined MnOE
with  a model of developmental stress already shown to
result  in long-term effects, i.e., the barren cage model that
uses  cages without normal bedding [36]. This cage condi-
tion  was  used to mimic  aspects found in impoverished low
SES  human environments [37–39]. We  previously used this
model  to assess developmental lead exposure in combina-
tion  with barren cage rearing [40]. Because the effects of
chronic  stressors are not reliably reﬂected in basal corti-
costerone levels, we  also used an acute stressor (shallow
water stress) to induce an acute stress response to test
for  differences in stress reactivity. The Mn-stress inter-
action exposure reported here is intended to be a model
for  future experiments on Mn  in combination with other
factors.
2.  Materials and methods
2.1.  Animals
All  protocols were approved by the Institutional Ani-
mal  Care and Use Committee. Animals were maintained in
a  AAALAC-accredited vivarium with regulated light cycles
(14:10  h light:dark cycle, lights on at 600 h) and con-
trolled temperature (19 ± 1 ◦C) and humidity (50 ± 10%).
Rats  had access to NIH-07 rodent chow and reverse osmo-
sis  ﬁltered, UV sterilized water provided ad libitum. The
NIH-07 diet contains consistent levels of metals, min-
erals, and other nutrients, thus providing a consistent
background nutritional formulation. Male and nulliparous
female Sprague-Dawley CD (IGS) rats (strain 001, Charles
River  Laboratories, Raleigh, NC) were bred following accli-
mation  to the facility for a minimum of 1 week. The
morning a sperm plug was  found was  designated embry-
onic  day 0 (E0). On E1 females were transferred to
polycarbonate cages (46 cm × 24 cm × 20 cm)  with wood-
chip bedding containing a stainless steel semicircular
enclosure as partial environmental enrichment [41]. Birth
was  counted as P0. On P1, litters were culled to 12 pups
(six  males and six females). If a litter had 10 or 11 pups,
one or two  pups from another litter with the same date
of  birth were fostered into the litter short of pups to
achieve uniform litter sizes. The study design by litter was
for  two  housing conditions × 3 assessment ages × 20 lit-
ters/cell = 120 litters. Litters were enrolled in the study on
a  rolling basis. Since litter outcomes could not be predicted
at  the time of enrollment, the number of litters actually
enrolled was 124. Two  litters were removed because the
dams  did not nurse their pups; hence, 122 litters were
used for data collection (Table 1). Mn  treatment and acute
stress  (0 or 30 min  in shallow water: shallow water stress
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(SWS)) were within-litter factors (see below). Pups were
individually identiﬁed by ear punch on P4.
2.2. Manganese over exposure and rearing
MnOE and differential rearing conditions were begun on
P4.  Rearing conditions (standard vs. barren) were adapted
from  [36] as described [40]. Brieﬂy, the woodchip bed-
ding  was  removed from cages in the barren condition and
replaced  with a paper towel, and the cages changed daily.
Standard cages with bedding and enclosures were also
changed daily to control for cage changing frequency. For
MnOE,  equal numbers of males and females per litter were
randomly assigned (using a random number table) to vehi-
cle  or one of two Mn  dose groups. Mn  was given as Mn
chloride tetrahydrate (cid 643989) dissolved in distilled
water (Sigma-Aldrich, St. Louis, MO). Within each litter,
four  pups (two males and two females) were gavaged with
0,  50, or 100 mg/kg Mn  in a volume of 3 mL/kg distilled
water (VEH) using a 24-gauge gavage needle with ball tip.
Doses  were expressed as the free metal. Pups were gavaged
to  avoid Mn  exposure to the dams and therefore prevent
effects on maternal behavior. We  showed [40] that gav-
aging  by experienced personnel does not signiﬁcantly alter
plasma  corticosterone levels when compared with non-
gavaged pups. Mn  was administered every other day from
P4  to P28. Offspring were sacriﬁced at three different ages:
P11,  19, and 29. For the group that continued to P29, wean-
ing  occurred on P28. On P28 pups were placed in standard
cages in same sex pairs until sacriﬁced 24 h later. One male
and  one female pair per Mn  group were euthanized by
decapitation at each assessment age.
2.3. Acute Stress and corticosterone assessment
For the acute stressor, rats were placed in shallow water
for  30 min  (SWS) as described [40,42,43]. SWS  consisted of
placing  rats in a standard rat cage with room-temperature
water ﬁlled to a depth of 2 cm on P11; 3 cm on P19, and
4  cm on P29. Some rats were euthanized immediately after
removal  from the water (time-0), while the remaining ani-
mals  were placed back in their home cages and euthanized
30  or 60 min  later. Litters not exposed to the SWS  were used
for  baseline plasma corticosterone and Mn  determinations,
and brains were dissected for monoamine neurotransmit-
ter assay. Blood was  collected in 12 × 75 mm polyethylene
tubes containing 0.05 mL of 2% EDTA, while an additional
blood sample was  taken from animals on P29 for Mn  anal-
ysis.  Corticosterone levels were determined from plasma
using  a commercially available EIA kit (Immunodiagnostic
Systems Inc., Fountain Hills, AZ) as described [40].
2.4. Monoamines
Rats not exposed to SWS  were used for neurotrans-
mitter determinations via high-performance liquid
chromatography with electrochemical detection (HPLC-
ECD)  and neostriatal Mn  concentrations. The neostriatum
(caudate and putamen), hypothalamus, and hippocampus
were dissected over ice using a 1 mm brain block [44]
and  rapidly frozen until analysis of monoamines was
logy Rep
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erformed as described [40]. Body weights were obtained
rom  the same animals. Dopamine (DA), homovanillic
cid (HVA), 3,4-dihydroxyphenylacetic acid (DOPAC),
erotonin (5-HT), 5-hydroxyindoleacetic acid (5-HIAA),
nd  norepinephrine (NE) were obtained from single chro-
atograms for each region per animal. Frozen tissues were
eighed,  thawed, and sonicated in appropriate volumes
f  0.1 N perchloric acid (Fisher Scientiﬁc, Pittsburgh, PA).
amples were centrifuged for 14 min  at 13,000 RCF at 4 ◦C.
he  supernatant sample was transferred to a new vial
or  injection onto a Supelco SupelcosilTM LC-18 column
150 × 4.6 mm,  3 m;  Sigma-Aldrich Co., St. Louis, MO).
he HPLC system consisted of a Waters 717plus autosam-
ler (Waters Corp., Milford, MA), ESA 584 pump (ESA, Inc.,
helmsford, MA), and ESA Coulochem III electrochemical
etector. The potential settings were −150 mV  for E1 and
250  mV  for E2, with a guard cell potential of +350 mV.
D-TM mobile phase (ESA, Inc.) was used and consisted
f  75 mM sodium dihydrogen phosphate (monohydrate),
ig. 1. Plasma corticosterone: plasma corticosterone prior to, immediately after
unction of rearing condition and Mn  exposure; see text for details. Top, corticost
29.  In each panel, corticosterone for rats reared in standard bedding is shown on
n  P19 represent main effects averaged across time of sacriﬁce. Group sizes wer
192),  Std. P29 = 24 (288), barren P11 = 21 (237), barren P19 = 20 (212), barren P2
er  cell. Values are mean ± SEM. *p < 0.05; **p < 0.01.orts 1 (2014) 1046–1061 1049
1.7 mM 1-octanesulfonic acid sodium salt, 100 l/l triethy-
lamine, 25 M EDTA, and 10% acetonitrile, with a ﬁnal pH
of  3.0. The pump ﬂow rate was  set at 0.7 mL/min, and the
samples were run at 28 ◦C. Standards for DA, DOPAC, HVA,
NE,  5-HT, and 5-HIAA (all obtained from Sigma-Aldrich
Co., St. Louis, MO)  were prepared in 0.1 N perchloric acid.
2.5. Mn concentrations
Rats  from the P29 age group were used for serum and
neostriatal Mn  determination as described [45]. Neostriatal
Mn  concentrations were measured with graphite furnace
atomic absorption spectrometry (GFFAAS, Varian AA240,
Varian, Inc., Palo Alto, CA). Neostriata were digested in
ultrapure nitric acid (1:10 wt/vol dilution) for 48–72 h in
a  sand bath (60 ◦C); 100 L of digested tissue was brought
to 1 mL  of total volume with 2% nitric acid and analyzed
for Mn.  For serum, a 400-L aliquot was  vortexed with
100 L of 0.5% Triton-X for 30 s and brought up to 1 mL  of
 (time-0), or 30 or 60 min  after removal from acute stressor (SWS) as a
erone on P11; middle, corticosterone on P19; bottom, corticosterone on
 the left and for those reared in barren cages is shown on the right. Insets
e: number of litters (number of pups): Std. P11 = 24 (264), Std. P19 = 17
9 = 16 (192). For each housing × treatment × age × acute stress N = 5–12
1050 C.V. Vorhees et al. / Toxicology Reports 1 (2014) 1046–1061
C
A B
D
Fig. 2. Neostriatal dopamine (DA): DA concentrations in neostriatum as a function of age, rearing condition, Mn exposure, and sex. A,B, males; C,
D,  females; A,C, standard cage condition; B, D, barren cage condition. Group sizes for this and all remaining ﬁgures are as follows: P11, Std. hous-
ing  (M/F): VEH = 5–10/4–10; Mn50 = 5–9/4–9; Mn100 = 5–9/6–9; barren housing (M/F): VEH = 6–10/5–9; Mn50 = 3–8/4–8; Mn100 = 4–9/4–8; P19, Std.
 housing
ng: VEHhousing (M/F): VEH = 5–9/6–9; Mn50 = 4–8/6–8; Mn100 = 5–9/6–8; barren
ing:  VEH = 4–10/2–10; Mn50 = 3–9/5–9; Mn100 = 2–7/4–7; barren housi
*P  < 0.05.
total volume with 2% nitric acid for analysis. The mixture
was  then centrifuged and the clear supernatant was used
for  analysis (100-L aliquot brought up to 1 mL  volume
with 2% nitric acid). A bovine liver (NBS Standard Refer-
ence  Material, USDC, Washington, DC) (10 g Mn/g) was
digested in ultra-pure nitric acid and used as an internal
standard for analysis (ﬁnal concentration 5 g Mn/L).
2.6.  Statistical analyses
All  data, except weekly body weights and mortality,
were analyzed using mixed linear factorial analysis of vari-
ance  (ANOVA; Proc Mixed, SAS v9.2, SAS Institute, Cary,
NC).  Factors were Mn  (0, 50, or 100 mg/kg), sex, rearing
condition (Standard or Barren), age (P11, P19, or P29), and
time  following SWS  (baseline, 0, 30, or 60 min). Litter was a
randomized  block factor in a completely randomized block
design  to account for litter effects. Signiﬁcant interactions
were followed-up using slice-effect ANOVAs. Body weights
in  the group euthanized on P29 were analyzed by gen-
eral  linear model ANOVA on even numbered days (Proc
GLM,  SAS). Where signiﬁcant interactions occurred on body
weight,  they were further analyzed by slice-effect ANOVA
and  pairwise group comparisons using the false discovery
rate  (FDR) method to control for multiple comparisons. Mn: VEH = 6–11/5–10; Mn50 = 7–10/6–9; Mn100 = 4–10/4–7; P29, Std. hous-
 = 4–9/3–9; Mn50 = 5–9/4–8; Mn100 = 4–6/3–8. Values are mean ± SEM.
exposure,  day, and sex were within-subject factors in GLM
analyses,  while rearing condition was  a between-subject
factor. Mortality data were analyzed by Fisher’s tests for
uncorrelated proportions. Signiﬁcance was set at p ≤ 0.05.
GLM  data are presented as mean ± SEM, and mixed data are
presented  as least square (LS) mean ± LS SEM.
3. Results
3.1. Mortality
Mortality data are shown in Table 1. Manganese at the
high  dose (Mn100) caused a signiﬁcant increase in offspring
mortality irrespective of rearing condition, i.e., both the
Mn100  Standard and Mn100 Barren cage reared groups
showed increased mortality (10.1 and 12.9%, respectively).
The apparent 3% increase in mortality in the Barren Mn100
group  was not signiﬁcantly different from that in the
Standard Mn100 group. There was  an apparent difference
in  mortality as a function of rearing condition in the Mn50
groups inasmuch as the Standard cage reared Mn50 group
had  less mortality than the Barren Mn50 group (i.e., 5.6 vs.
9.6%)  but the difference was not signiﬁcant (X2(1) = 2.84,
p  > 0.05.
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sterisk  on the Mn50 P19 females is for the mean effect across housing co
.2. Body weights
Because treatment was from P4 to P28, body weight
ata were analyzed during this period separately from
ody  weights after MnOE. A Mn  × sex × rearing con-
ition × age ANOVA with age as a repeated measure,
howed effects of Mn  (F(2,362) = 82.7, p < 0.0001), sex
p  < 0.005), day (p < 0.0001), Mn  × day (F(12,2378) = 41.6,
 < 0.0001), sex × day (p < 0.0001), and rearing condi-
ion × day (p < 0.0001). The Mn  × day interaction was
ollowed up with slice-effect ANOVAs on each day. In
hese  analyses, the effect of Mn  was signiﬁcant on P8–P28
p  < 0.001) but not on P4. Pairwise comparisons by FDR tests
re  summarized in Table 1. At P8 only the Mn100 group
iffered from control, whereas, from P12 to P28, both Mn
roups  differed from VEH in both standard and barren cage
eared  rats. For all biochemical determinations, group sizes
re  summarized in ﬁgure captions.
.3. Mn  Concentrations
Rats  treated with Mn (100 mg/kg) had signiﬁcantly
levated levels of Mn  in the neostriatum relative
o VEH-treated rats (F(1,23) = 230.3, p < 0.0001), i.e.,
EH  = 0.39 ± 0.12 g/g vs. Mn100 = 2.39 ± 0.12 g/g
issue. Serum Mn  levels were somewhat elevated
F(3,31) = 1.58, p < 0.10), i.e., VEH = 11.67 ± 4.75 g/Lfunction of age, rearing condition, Mn  exposure, and sex. A,B, males; C,
oup sizes shown in Table 3. Values are mean ± SEM. *p < 0.05. Note: the
.
vs.  Mn100 = 16.62 ± 4.75 g/L (note: SEMs are the same
because they are LS SEMs).
3.4.  Corticosterone
In  the overall ANOVA, only one signiﬁcant Mn-related
effect was found, which was the Mn  × rearing condi-
tion × age interaction (F(4,1004) = 2.78, p < 0.05). In order
to  sort this, ANOVAs were conducted for Mn  for each age
and  rearing condition. At P11 there were no signiﬁcant
effects of Mn,  rearing condition, or SWS  (Fig. 1, top). At P19
for  Standard housing, there were both Mn  (F(2,198) =3.11,
p  < 0.05) and Mn  × SWS  effects (F(6,198) = 3.87, p < 0.01).
The  Mn  main effect was the result of increased corticoste-
rone in the Mn-exposed groups (Fig. 1, middle, left inset).
Slice  ANOVAs on the interaction showed a Mn  effect imme-
diately  upon removal from the SWS  (time-0) in which
the  Mn-exposed groups showed increased corticosterone
compared with VEH (Fig. 2, middle-left). At P19 for bar-
ren  housing, there was a signiﬁcant main effect of Mn
(F(2,231) = 3.38, p < 0.05), but no interactions. The main
effect was attributable to reduced corticosterone in the bar-
ren  Mn100 group, but note that this was  against a higher
pre-SWS in the barren housing groups than in the standard
housing groups (Fig. 1, middle, right inset, and cf. mid-
dle,  left inset). There was, at this age, a signiﬁcant SWS
main effect (F(3,231) = 15.47, p < 0.0001). At P29 for both
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across  housing condition. Range of group sizes shown in Table 3. Values a
standard and barren housing, there were no signiﬁcant
main effects or interactions with Mn.  There were main
effects of SWS  (Standard F(3,198) = 51.44, p < 0.0001; bar-
ren  F(3,176) = 50.58, p < 0.0001) (Fig. 1, bottom).
3.5.  Monoamines
3.5.1. Neostriatum
There were no signiﬁcant effects of Mn  or rearing
condition on 5-HT in the neostriatum at any age (not
shown). For DA, there was a signiﬁcant Mn  × rearing
condition × age × sex interaction; (F(4,220) = 2.45, p < 0.05,
Fig.  2A-D). Slice and FDR analyses revealed the effect to
be  in the female standard housed Mn100 group (Fig. 2C)
at  P19 in which the Mn100 group showed increased
DA compared with standard housed VEH females at
this  age. No signiﬁcant treatment effects were found
on DOPAC. For neostriatal NE, there were signiﬁcantas a function of age, rearing condition, Mn  exposure, and sex. A,B, males;
 males averaged across housing condition; F, effects in females averaged
 ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001.
Mn (F(2,186) = 9.11, p < 0.001) and Mn  × sex × age effects
(F(4,186) = 5.3, p < 0.001). Slice ANOVAs and pairwise com-
parisons  showed the pattern illustrated in Fig. 3 in
which there were increases in NE in female Mn50 and
Mn100 groups at different ages irrespective of hous-
ing  condition compared with VEH females. Similarly,
there was a Mn  main effect on HVA in the neostriatum
(F(2,209) = 5.59, p < 0.01: Fig. 4) and a Mn  × age × sex inter-
action (F(4,209) = 3.28, p < 0.05). When the latter effect was
further  analyzed, the effects occurred in the male Mn50 and
Mn100  groups at P19 and in females in the Mn100 group
at  P29, both irrespective of rearing condition (Fig. 4, panels
E  and F in which rearing conditions were combined).3.5.2. Hippocampus
Monoamine levels in the hippocampus were also
affected by Mn  and rearing condition (Fig. 5). A signiﬁcant
main effect of Mn  (F(2,129) = 3.43, p < 0.05) was  evident for
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A, such that Mn  groups had increased DA compared with
EH  (Fig. 5E); the main effect of rearing condition showed a
rend  toward increased DA across all barren reared groups
(1,129) = 3.59, p ≤ 0.06). For hippocampal NE, there were
igniﬁcant Mn  × age (F(4,168) = 3.53, p < 0.01: Fig. 6) and
n  × sex × age interactions (F(4,168) = 2.46, p < 0.05). Fur-
her  analyses showed these to be predominantly expressed
n  males irrespective of rearing condition and occurred in
he  Mn50 group at P11 and in the Mn100 group at P29
both were increases; Fig. 6E). Hippocampal 5-HT showed
 Mn  main effect (F(2,171) = 11.33, p < 0.0001: Fig. 7) and
 Mn  × age interaction (F(4,171) = 2.42, p < 0.05). Further
nalysis showed that the main effect was attributable to
ncreased 5-HT in the Mn  groups, whereas, the Mn  × age
nteraction showed the effect to be predominately on P29
Fig.  7E). For 5-HIAA, the only effect was a Mn  × age inter-
ction which when further analyzed was attributable toction of age, rearing condition, Mn exposure, and sex. A,B, males; C, D,
 across sex, housing condition, and age to show main effect of Mn.  Range
reduced  5-HIAA in the Mn  groups at P19 irrespective of sex
or  rearing condition (Fig. 7F).
3.5.3. Hypothalamus
Monoamines in the hypothalamus were altered
(Figs. 8 and 9). For DA there was  a four-way interac-
tion of Mn × sex × rearing condition × age (F(4,206) = 2.4,
p  < 0.05). When further analyzed, this interaction was
attributable to DA increases in the barren-housed female
Mn100 group at P19 and both Mn  groups at P29 compared
with VEH animals at those ages (Fig. 8D). There were
no  signiﬁcant treatment effects found on DOPAC. For
hypothalamic NE, there was also a four-way interaction
of Mn  × sex × rearing condition × age (F(4,216) = 3.03,
p < 0.05). In this case, further analysis showed increases in
NE  in standard-housed males at P29 in the Mn100 group
and  a trend in the Mn50 group (Fig. 9A) and a similar
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trend in the barren Mn100 females at this age (Fig. 9D).
For  HVA, there was a signiﬁcant Mn  × sex interaction
(F(2,123) = 3.33, p < 0.05; Fig. 10) which when further
analyzed was attributable to increased HVA in the Mn100
males  compared with VEH males (Fig. 10E). There were
no  signiﬁcant Mn  or rearing effects on hypothalamic 5-HT
(Fig.  11A–E). A main effect of Mn  was found for 5-HIAA
(F(2,213) = 3.75, p < 0.05) in which the Mn  groups had
lower 5-HIAA levels than VEH animals irrespective of sex
or  housing condition (Fig. 11F).
As noted in methods, litters one or two pups short of
the  12 needed per litter had one or two pups in-fostered
from litters born within 24 h of the litter that had too few
born.  Out of the 116 litters used for corticosterone and
monoamine determinations, a total of 36 pups out of 1392
pups  were in-fostered or 2.6%. Within the standard hous-
ing  condition a total of 22 pups were in-fostered out of
696  pups or 3.2%. Within the barren housing condition a
total  of 14 pups were in-fostered out of 696 pups or 2.0%, a function of age, rearing condition, Mn exposure, and sex. A,B, males; C,
veraged across housing to show Mn effects on males (E) and females (F).
making  it unlikely that this proportionately small amount
of  in-fostering would signiﬁcantly impact either the cor-
ticosterone or monoamine responses of the treatment
groups.
4. Discussion
This experiment tested whether two dose levels of Mn
during postnatal development under standard or barren
cage  rearing conditions altered corticosterone and brain
monoamines at different developmental ages. This was
based  on the observation that excess Mn  exposure dur-
ing  development is a signiﬁcant problem in some areas
in  the U.S. and many other countries where industrial
Mn pollution or well water naturally high in Mn  result
in  MnOE-induced neurotoxicity. We  included an environ-
mental deprivation rearing condition (barren housing) to
model  chronic developmental stress because MnOE more
often  occurs in regions of lower SES, stress, and physical
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nd social hardship. In order to test these conditions on
he  HPA axis we measured corticosterone before and after
n  acute stressor (standing in shallow water for 30 min).
Reduced body weight was found during treatment in
oth  Mn-treated groups regardless of housing condition.
he literature on developmental Mn  exposure and body
eight  effects is mixed. One study that exposed rats to
n  throughout gestation and lactation and, similar to the
resent  experiment, found signiﬁcant body weight reduc-
ions  during treatment [46] as did a study giving Mn  in
rinking water to rats from P1 to P80 in which reduced
ody weight occurred in the high-dose group but not in
he  mid  or lower dose groups [47]. In another study in rats
reated  with Mn  by gavage, as we did, from P1 to P21, MnOE
ats  had reduced body weights at the two doses tested
25  and 50 mg/kg/day); their high dose being equivalent
o our low dose [48]. There is also a report of prenatal Mn
xposure causing reduced fetal weight [49]. In contrast to
hese  reports, there is one report of gestational and lacta-
ional  Mn exposure in rats ﬁnding increased body weightnction of age, rearing condition, Mn  exposure, and sex. A,B, males; C, D,
ect of Mn on 5-HT (E) and 5-HIAA (F) across housing condition and sex.
.001.
in  females during and three weeks after the end of treat-
ment but no changes in males [50]. Several studies report
no  change in body weight resulting from pre-weaning Mn
exposure: one found no change in body weight on P8 or
P29  in rats from Mn  exposure from P8 to P27, however, this
study  used doses lower than ours [51]. Another study found
no  change in body weight in rats at P21 after Mn  exposure
from P1 to P20, again at doses lower than ours [23]; and
another study found no differences in body weight after
P1–P21  Mn  exposure in rats long after exposure when the
animals  were adults, but report no data on body weight
during treatment [52]. There is also a study in rats using
Mn  that found no body weight differences in the offspring
at  P21 after prenatal-only exposure, also at doses below
ours  (5 mg/kg/day vs. our 50 mg/kg/2 days) [53]; and a
study  in rats using later Mn  exposure starting at P21 that
found  no body weight differences [54]. Somewhat surpris-
ingly,  there are also a number of developmental Mn  studies
that  are silent concerning body weight. Four prewean-
ing exposure studies in rats [9,55–57] and ﬁve using
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exposures that started on P21 ([58–62]) make no mention
of  body weight. It is difﬁcult to draw conclusions from the
above  with so many studies not mentioning body weight.
Several studies gave 25 mg/kg every day, essentially com-
parable  to our 50 mg/kg every other day dose, and found
body  weight reductions during treatment and one study
found  increased body weight after gestational and lacta-
tional  exposure, a ﬁnding difﬁcult to reconcile with the
overall  pattern of reduced or no change in body weight in
the  majority of studies. In a follow-up experiment using
100  mg/kg Mn/2 day we have replicated the body weight
reduction seen here (unpublished observations), indicat-
ing  that the present body weight changes are not a false
positive result.
We  found a modest increase in prenatal mortality asso-
ciated with MnOE at the 100 mg/kg/2 day dose reared
under standard housing conditions (10.1%) but not at
50  mg/kg/2 day. In barren cages, both doses increased
mortality (9.6% and 12.9% in the 50 and 100 mg/kg/2 day
doses,  respectively). The latter is presumably the result
of  an interaction of Mn  and stress on survival. Of all
the  studies reviewed above, most make no statement of
morality,  i.e., they fail to state whether there was  any
change or not. There is one report of increased mortality
in rats associated with P21–P81 Mn  exposure [54] and one
report  of increased resorptions from prenatal Mn exposure
[49].  Interestingly, there is one human epidemiological
study showing a signiﬁcant association between infantnction of age, rearing condition, Mn exposure, and sex. A,B, males; C, D,
 sizes shown in Table 3. Values are mean ± SEM. *p < 0.05.
mortality and Mn  ground water concentrations across the
state  of North Carolina [63]. It is difﬁcult to interpret the
present mortality data in light of the silence of other reports
on  this point.
Neither Mn  nor barren cage rearing altered baseline
corticosterone at the ages tested, but immediately after
the  acute SWS  stressor exposure, standard housed Mn
groups showed an exaggerated increase in corticosterone
on P19. This response was absent in Mn  exposed groups
raised in barren housing, suggesting that chronic stress
attenuates the normal acute stress response at this age. In
terms  of rearing condition alone, housing produced only a
trend  main effect (F(1,1004) = 2.87, p ≤ 0.09) but it modiﬁed
the  corticosterone response to acute stress. This inﬂuence
appeared on P19 also in which barren housed rats showed
increased corticosterone after acute stress compared with
standard-housed controls. This change was different when
Mn  effects were overlaid on this pattern. Barren housing
suppressed the corticosterone increase caused by Mn  at
P19.  At P29, where no Mn  effects on corticosterone were
observed, there was  a large effect of housing in which
barren housed animals showed a larger response to acute
stress  at time-0 as reﬂected in a three-way interaction of
housing  × age × time (F(6,1004) = 4.16, p < 0.001).Housing had no main effects on neostriatal, hip-
pocampal, or hypothalamic monoamines or their principal
metabolites, although it was  an interacting factor with Mn
at  some ages. These interactions with Mn  were complex
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s they were age-speciﬁc and in some cases both age-
nd  sex-speciﬁc. However, some common threads may  be
iscerned.  The most apparent of the effects of Mn  on neu-
otransmitters was that Mn,  in nearly every case where it
ad  signiﬁcant effects, increased NE, DA, and 5-HT. In no
ase  did Mn  exposure decrease monoamine neurotrans-
itters. Moreover, where changes in the metabolites HVA
r  5-HIAA were seen, they were decreased in one or both
f  the Mn exposed groups.
What is more difﬁcult to ascertain was the age by region
ffects of Mn  exposure. Overall, P11 showed the fewest
ffects; only one P11 effect was seen (P11 Mn50 increase
n  hippocampal NE). It seems likely that since Mn  expo-
ure  began on P4, and if the effects of Mn  are cumulative,
11 may  have been too soon after the beginning of expo-
ure  to show many effects. In terms of number of effects,
19  appeared to be the most sensitive; most of the effects
ound were at this age. P29 showed an intermediate num-
er  of effects, the most striking of which were Mn-induced
ncreases in hippocampal NE and hypothalamic NE and DA.
hile  these effects were not always dose-dependent, in
eneral  the Mn100 groups showed more effects than the
n50  groups. Table 2 shows a summary of the pattern of
onoamine changes.
Two  other studies from the same laboratory measured
triatal DA concentrations in rats after developmental Mn
xposure.  Rats were exposed to Mn  by gavage from P1 to
21  and reduced striatal DA was found, on P40, 19 dayss a function of age, rearing condition, Mn  exposure, and sex. A,B, males;
roup sizes shown in Table 3. Values are mean ± SEM. *p < 0.05.
after  the end of treatment [23] and on P65, 41 days after
the  end of treatment [9]. While these ﬁndings contrast
with ours, Tran et al.’s ﬁndings were long after treat-
ment, whereas, ours were during treatment. Two studies,
from  the same group, measured DA D1 and D2 recep-
tors and DA transporter (DAT) in frontal cortex, striatum,
and nucleus accumbens [48,57]. Data for rats at two  dif-
ferent  ages are reported, P24 and P107 after P1–P21 Mn
exposure to 25 or 50 mg/kg/day. The P24 data are the
same in both reports. Effects were varied by brain region,
age,  and outcome. D1 levels were unchanged in frontal
cortex, decreased in striatum at P24 but not at P107,
and decreased in nucleus accumbens at 50 mg/kg at P24
but  only in the 25 mg/kg group at P107. D2 levels were
increased in frontal cortex in the 50 mg/kg group at both
ages,  whereas, D2 was  unchanged at both ages and at
both  doses in the striatum and nucleus accumbens. DAT
levels  were unchanged in frontal cortex, and reduced in
the  50 mg/kg group at P24 but not at P107. These DA-
related markers suggest a complex pattern of decreases
in  D1 and DAT in basal ganglia with opposite increases
in D2 in frontal cortex. Another study in rats looked at
postsynaptic markers of monoaminergic signaling, [56],
including striatal ERK1/2, AKT, and DARPP32 phosphory-
lation, after short-term, P8–P12, exposure to Mn  by i.p.
injection and these parameters were measured 48 h later
on  P14. They used three doses of Mn  (5, 10, and 20 mg/kg)
and  found increased pERK1/2 at 20 mg/kg Mn,  increased
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Fig. 10. Hypothalamic homovanillic acid (HVA): HVA concentrations in hypothalamus as a function of age, rearing condition, Mn  exposure, and sex. A,B,
males;  C, D, females; A,C, standard cage condition; B, D, barren cage condition. E, effects averaged across sex, housing, and age to show main effects of Mn.
Range  of group sizes shown in Table 3. Values are mean ± SEM. *p < 0.05.
Table 2
Standard Barren
Male Female Male Female
Region 11 19 29 11 19 29 11 19 29 11 19 29
Neostr. DA – – – – ↑H – – – – – – –
NE – – – ↑L ↑L ↑H – – – – ↑L –
5HT
Hipp. DA ↑H and L main effect
NE – – – – – – ↑L – ↑H – – –
5HT – – ↑H and L – – ↑H and L ↑H and L ↑H and L
Hypo.  DA – – – – – – – – – – ↑H ↑H and L
NE – – ↑H – – – – – – – – –
5HT – – – – – – – – – – – –
L = Low dose (Mn50).
H = High dose (Mn100).
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AKT at 10 and 20 mg/kg, and increased pDARPP32 at 5 and
0  mg/kg. While not speciﬁcally DA-related, these striatal
arkers all overlap with dopaminergic signaling, suggest-
ng  again that developmental Mn  exposure affects striatal
A  pathways. But DA is not the only neurotransmitter
eported to be affected by developmental Mn  exposure.
wo studies report changes related to GABA [58,60] when
n  exposure started on P21. One found that Mn  reduced
ABA release in striatum following nipecotic acid-induced
elease. The other found that Mn  exposure reduced hip-
ocampal glutamic acid transaminase (GAT-1), increased
ABAA protein, and reduced GABAB mRNA expression.
e also found an increase in hippocampal 5-HT which
o  one else has examined. While most of the reported
ffects of developmental Mn  suggest decreased DA-related
arkers, these ﬁndings are mostly found long after Mn
xposure, whereas, we measured during exposure. Taken
ogether with data from these other studies, Mn  can induce function of age, rearing condition, Mn  exposure, and sex. A,B, males; C, D,
of Mn on hypothalamic 5-HT (E) and 5-HIAA (F) across housing condition,
0.05.
neurotransmitter changes, but these changes are likely
speciﬁc to the timing of the exposure and when the neuro-
transmitters are assessed. Takeda et al., [16] found that the
deposition of Mn  in the brain was  dependent on the age of
exposure  which suggests that the effects of Mn  during dif-
ferent  exposure periods may  differ. It will be necessary to
determine  if increases we observed change after exposure
has  ended.
The results support the general notion that develop-
mental Mn  exposure causes brain monoamine changes.
How long these changes persist is unknown, as are whether
they  result in functional changes to neurobehavior. It may
be  that neuroplastic compensatory processes occur such
that  after a recovery period neurotransmitters return to
control  levels or even decrease. Alternatively, these early
changes may  result in enduring functional changes as
others  have found with developmental MnOE [6,7,9], i.e.,
while  the level of a neurotransmitter may  change following
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treatment there may  be downstream, enduring changes to
receptors,  second messengers, or modulators that result in
neurobehavioral changes (see above). Functional changes
to  behavior and cognitive development may  be present
either during or after Mn  exposure and will require further
experiments to determine if this is the case.
We found few interactions between the chronic stress of
barren  housing and Mn  exposure except on corticosterone.
For monoamines, barren housing caused no effects in and
of  itself. However, chronic developmental stress has been
shown  to affect brain and behavior in other studies [31–35].
There  is a critical period for neonatal stress that results in
altered  behavior, reduced LTP, and lower spine density in
cortical  layer 5 and anterior cingulate compared with non-
stressed  animals [31,33,34]; whereas, in humans increased
amygdala size is reported after chronic early stress [35].
Limitations of the present experiment include that only
two  doses of Mn  were assessed and only one period of
developmental exposure was used (P4–P28). It may  be
that  other doses or other developmental exposure periods,
perhaps including prenatal exposure, would produce dif-
ferent  effects. Only monoamine neurotransmitters were
assessed  and in only three brain regions. Mn  may  affect
other neurotransmitter, neurotrophins, receptors, trans-
porters,  or morphology that were not examined here. As
noted  above, this experiment did not include assessments
of  the permanence of the changes observed or test for
their  effects on cognitive or other behavioral functions.
We  fostered one–two pups into litters short one or two
pups; across the study this amounted to 2.6% of pups in-
fostered, a proportion unlikely to impact the ﬁndings (see
[64]).  It is also worth mentioning that rats were weaned
on  P28 and the last samples were taken on P29, only
24  h post-weaning which could conceivably be an added
stressor. A comparison of the P19 baseline levels of cor-
ticosterone and the P29 baseline levels in controls shows
that  corticosterone levels were lower on P29 than on P19,
suggesting that weaning was not a stressor. Despite limita-
tions,  the data demonstrate that developmental Mn  alters
brain  neurotransmitters in several brain regions important
for  behavior and the effects were age- and sex-dependent.
The data suggest that developmental Mn  exposure should
be  investigated further for possible long-term effects.
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